A 72-year-old woman and a 72-year-old man can share the same checklist of dementia risk factors: untreated high blood pressure, little physical activity, hearing loss left unaddressed. But according to a UC San Diego analysis of roughly 17,000 older Americans, those identical risks do not produce identical outcomes. The woman’s cognitive scores drop faster. Her brain, the data suggest, absorbs more damage from the very same exposures.
Published in Alzheimer’s & Dementia, the study was led by first author Megan Fitzhugh and corresponding author Judy Pa. Their findings challenge a default assumption that has shaped dementia prevention for decades: that modifiable risk factors erode thinking skills at roughly the same rate in both sexes. If the results hold up under replication, they could reshape how clinicians screen for and manage cognitive risk in women.
What the researchers did
Fitzhugh and Pa drew on the Health and Retirement Study, a longitudinal survey run by the University of Michigan’s Institute for Social Research. The HRS has tracked health conditions, behaviors, cognition, and biomarkers across a nationally representative sample of Americans over age 50 since the early 1990s. Its peer-reviewed cohort profile, published in the International Journal of Epidemiology, documents the survey’s design, recruitment waves, and cognitive testing batteries, giving the UC San Diego team a large, well-validated dataset for isolating sex-specific patterns in cognitive aging.
The researchers structured their analysis around the risk-factor framework from the Lancet Commission on dementia prevention, which identifies 14 modifiable contributors to dementia and estimates each factor’s share of the overall disease burden through population attributable fractions. That framework is the most widely cited tool in dementia prevention research and has shaped public health guidelines worldwide. By applying the Commission’s list to the HRS data, Fitzhugh and Pa could compare how the same recognized risks tracked with cognitive scores in women versus men.
The team used repeated cognitive assessments collected over several HRS waves, following trajectories rather than relying on one-time snapshots. Global cognition scores in the HRS typically combine memory tasks, word recall, and mental status questions into a composite measure that can be tracked as participants age. To minimize confounding, the analysis adjusted for age, race and ethnicity, baseline education, and other demographic variables. The researchers also accounted for the cumulative number of risk factors present, recognizing that dementia risk often reflects layered exposures rather than any single cause.
What they found
The pattern was consistent across multiple risk factors: women exposed to the same modifiable risks showed steeper drops in global cognition scores than men with equivalent exposures. The finding held after adjusting for the Lancet Commission’s weighting of each factor’s relative contribution to dementia risk. In practical terms, a woman and a man who share the same cluster of risks would not face equal cognitive consequences. The woman’s trajectory, according to this data, bends downward more sharply.
Even after controlling for the fact that women live longer on average and may start with different educational or socioeconomic profiles, the sex gap in decline persisted. That persistence is what makes the finding notable: it suggests the disparity is not simply a statistical artifact of longevity or life-course differences but may reflect something about how female biology interacts with these risk exposures.
The study also builds on earlier scientific consensus about why biological sex deserves separate examination in Alzheimer’s research. A 2016 paper convened by the Women’s Alzheimer’s Research Initiative and published in Alzheimer’s & Dementia argued that hormonal fluctuations, genetic susceptibility (particularly the APOE4 gene variant, which confers greater Alzheimer’s risk in women than in men), and immune-response differences all justify sex-stratified analyses. Fitzhugh and Pa cited that work directly as part of their scientific rationale.
What remains uncertain
The study’s full regression coefficients and interaction terms, the statistical details that would quantify exactly how much worse each individual risk factor is for women compared with men, are behind a journal paywall. Without those numbers, independent observers cannot yet verify the precise magnitude of the sex gap for any single factor such as hypertension, obesity, or depression. The university’s public summary confirms the direction of the finding but does not report effect sizes for individual risks.
The biological mechanism driving the disparity is also unresolved. Plausible pathways include estrogen loss after menopause, sex-linked differences in APOE4 gene expression, and female-specific patterns of neuroinflammation. But the UC San Diego study is observational: it can show that women’s cognition declines faster under the same risk load, but it cannot prove why. Confirming any mechanistic explanation would require targeted studies or randomized trials that this dataset was not designed to support.
There is also a measurement question. The HRS includes biomarker collection waves with lab values such as cholesterol levels and inflammatory markers, but whether the UC San Diego team incorporated those objective measures or relied primarily on self-reported health conditions is not fully detailed in the institutional summary. That distinction matters because women and men may report symptoms differently. If women are more likely to disclose depressive symptoms or hearing difficulties, for instance, some portion of the observed gap could reflect reporting patterns rather than true biological vulnerability.
Finally, the timing of risk exposure is hard to pin down. Because the HRS focuses on adults over 50, it captures midlife and late-life risk factors more effectively than childhood or early-adult experiences. If women accumulate risk earlier through interruptions in education, caregiving-related stress, or delayed treatment of cardiovascular conditions, those life-course patterns might help explain why the same risk profile at age 70 appears more damaging in women.
What this means for prevention
Dementia prevention guidelines from major health organizations, including the World Health Organization and the Alzheimer’s Association, still treat modifiable risk factors as sex-neutral. A woman who controls her blood pressure, stays physically active, and maintains social connections is following the best available evidence for brain health. What the UC San Diego findings add is a reason to suspect those efforts may need to start earlier or be pursued more aggressively in women to achieve the same protective effect.
If the results are replicated, several practical shifts could follow: sex-stratified risk calculators, earlier screening thresholds for women, or targeted public health messaging. Clinicians might consider tighter blood pressure targets in midlife women or more proactive screening for hearing loss and depression, both of which the Lancet Commission identifies as significant modifiable contributors to dementia.
For patients and families, the message is not cause for alarm but a prompt to personalize. Women who carry several recognized risk factors, such as diabetes, physical inactivity, social isolation, or a history of stroke, may want to discuss a more intensive prevention strategy with their physicians. Men with similar profiles should not be complacent; the same factors still raise their dementia risk, even if the relative cognitive toll appears smaller in this analysis.
Why the sex gap in Alzheimer’s has never been fully explained
About two-thirds of Americans living with Alzheimer’s disease are women, according to the Alzheimer’s Association. Longevity has always been part of the explanation: women live longer, and age is the strongest risk factor for dementia. But longevity alone has never accounted for the full imbalance, and researchers have spent years trying to identify what else is at work.
The UC San Diego study sharpens that question. By showing that identical modifiable risks may erode women’s cognition more quickly than men’s, it points toward an interaction between sex-specific biology and life-course exposures that current prevention guidelines have not yet captured. Future research combining large cohorts, detailed biomarker data, and mechanistic studies will be needed to untangle those interactions. But the direction is increasingly clear: dementia prevention is unlikely to be one-size-fits-all, and accounting for sex may be one of the most consequential next steps the field can take.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
